Edouard Dahl
Directeur/Membre du Conseil chez DEVONIAN HEALTH GROUP INC.
Fortune : - $ au 30/04/2024
Profil
Edouard Dahl is an Independent Director at Devonian Health Group, Inc. since 2023.
He was previously a Director of Mergers & Acquisitions at Sanofi Canada, Inc. He obtained his undergraduate degree from Concordia University in 1979.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/05/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Edouard Dahl
| Sociétés | Poste | Début |
|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Directeur/Membre du Conseil | 12/05/2023 |
Anciens postes connus de Edouard Dahl
| Sociétés | Poste | Fin |
|---|---|---|
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Corporate Officer/Principal | 24/03/2023 |
Formation de Edouard Dahl
| Concordia University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DEVONIAN HEALTH GROUP INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |